ArticleFrontiers in immunology2026

A predictive model for low-dose rituximab response in anti-acetylcholine receptor antibody-positive myasthenia gravis: establishment and validation.

Chenlu Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.